Oil and Gas Exploration Co. Reports Strong Production
Research Report
PDUFA Date Nearing for New PSVT Drug
Research Report
Resource of Project in Spain Increases 37%
Research Report
Oil & Gas Co. Raising Funds To Get Back to Growth
Research Report
US Co. with Antimony Asset to Ask EXIM for Financing
Research Report
Co. With FS-Stage Asset Gains Analyst Coverage
Research Report
Research Firm Resumes Coverage on Silver Miner
Research Report
BC Gold Co. Makes List of Objectives for This Year
Research Report
This 16-item compilation "outlines a clear path forward and priorities," noted a Red Cloud Securities report. Silver Co. Moves Up to TSX
Research Report
This upgrade is one of many moves this Canadian explorer has made this year, noted a Beacon Securities report. Drill Bit Hits High-Grade Silver, Gold in Stepouts
Research Report
These results, from a project in Argentina, will be included in the upcoming mineral resource estimate update, noted a Raymond James report. Co. Reaches Major Milestone in the Transition From Developer to a Producer
Research Report
Atlas Lithium Corp. (ATLX:NASDAQ) recently announced the entrance of its Dense Media Separation (DMS) processing facility in Brazil, according to an Alliance Global Partners research note. Utah Biotech's Treatment Demonstrates Significant Survival Advantage for ALS Patients
Research Report
Utah biotech Clene Inc. (CLNN:NASDAQ) recently shared new data, reporting the survival benefit of its CNM-Au8 treatment for ALS patients, according to a D. Boral Capital research note. Biotech Advancing Pivotal Phase III Breast Cancer Trial
Research Report
Oncolytics Biotech Inc. (ONCY:NASDAQ; ONC:TSX) recently updated its timelines for the company's clinical testing, regulatory review, and potential commercial launch of its oncolytic reovirus formulation pelareorep in breast cancer, according to a report from Leede Financial Inc. New Drug for Major Depressive Disorder Gets Good Surprise
Research Report
When a key competitor drops out, this treatment moves to top runner position; the biopharma behind it offers 1,084% upside, noted an H.C. Wainwright & Co. report. With Competitor Out, New Drug Gains Edge in Chronic Cough
Research Report
Phase 2b data, expected in H1/25, could support advancement of the therapeutic into late-stage development, noted a D. Boral Capital report. FDA OKs Trial of Cell Reservoir in Thyroid Disease
Research Report
In this Phase 1 study, post-thyroidectomy patients will be treated with their own thyroid cells via this implantable delivery device, noted a Leede Financial Inc. report. 
Streetwise Key Charts
